EVE Health Group (ASX:EVE) DeferredTaxAndRevenue: A$0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is EVE Health Group DeferredTaxAndRevenue?

EVE Health Group ASX:EVE DeferredTaxAndRevenue is A$0.00 Mil as of Dec. 2025. The stock has 6 warning signs investors should review.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

EVE Health Group's current deferred tax and revenue for the quarter that ended in Dec. 2025 was A$0.00 Mil.

EVE Health Group DeferredTaxAndRevenue Related Terms

EVE Health Group DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for EVE Health Group's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EVE Health Group DeferredTaxAndRevenue Chart

EVE Health Group Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
DeferredTaxAndRevenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

EVE Health Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of A$0.00 Mil mean?
EVE Health Group (ASX:EVE) has a DeferredTaxAndRevenue of A$0.00 Mil as of Dec. 2025. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on EVE Health Group.
Is EVE Health Group's DeferredTaxAndRevenue too high?
EVE Health Group's current DeferredTaxAndRevenue is A$0.00 Mil.
How does EVE Health Group's DeferredTaxAndRevenue compare to KHC and GIS?
EVE Health Group's DeferredTaxAndRevenue of A$0.00 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Consumer Packaged Goods company?
A good DeferredTaxAndRevenue depends on the Consumer Packaged Goods industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on EVE Health Group. EVE Health Group's current DeferredTaxAndRevenue is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EVE Health Group stock overvalued right now?
Based on GuruFocus' analysis, EVE Health Group (ASX:EVE) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.01, compared to a current price of A$0.02 — trading 70% above its estimated fair value. The current DeferredTaxAndRevenue is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For EVE Health Group (ASX:EVE), the current DeferredTaxAndRevenue is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

EVE Health Group Business Description

Address 245 Churchill Avenue, Suite 1, Subiaco, WA, AUS, 6008
EVE Health Group Ltd is an integrated Health, Nutrition, and Wellness investment company. The company operates in two reporting segments, namely Meluka (branded wellness consumer products) and Nextract.